Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S de Bono

Showing results (81-90 of 492) with videos related to

Pageof 50
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2016
Biopsy-Derived Biomarkers in Phase I Trials: Building Confidence in Drug DevelopmentTimothy A Yap, Udai Banerji, Johann S de Bono, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2010
Studies of TMPRSS2-ERG gene fusions in diagnostic trans-rectal prostate biopsiesGerhardt Attard, Johann S de Bono, Jeremy Clark, et al.
Genome Biology|September 16, 2014
The promise of circulating tumor cell analysis in cancer managementJoaquin Mateo, Marco Gerlinger, Daniel Nava Rodrigues, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Opportunities and pitfalls of targeted therapeutic combinations in solid tumorsJoaquin Mateo, Michael Ong, Timothy A Yap, et al.
European Urology|September 5, 2017
Reply to Finn E. von Eyben, Irene Virgolini and Giandomenico Roviello's Letter to the Editor re: Silke Gillessen, Gerhardt Attard, Tomasz M. Beer, et al. Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017. Eur Urol 2018;73:178-211Silke Gillessen, Johann S de Bono, Oliver Sartor, et al.
Journal of Musculoskeletal & Neuronal Interactions|March 31, 2007
Influence of birth weight and early diet on peripheral bone in premenopausal Cambridge women: a pQCT studyM A Laskey, S de Bono, E C Smith, et al.
Nature Clinical Practice. Urology|November 6, 2008
CYP17 inhibition as a hormonal strategy for prostate cancerAlison Hm Reid, Gerhardt Attard, Elaine Barrie, et al.
BMJ (Clinical Research Ed.)|August 13, 2008
New prostate cancer drug: Prostate cancer's day in the sunGerhardt Attard, Alison H Reid, David Dearnaley, et al.
Current Oncology Reports|February 8, 2012
FGF receptor inhibitors: role in cancer therapyGennaro Daniele, Jesus Corral, L Rhoda Molife, et al.
Cancer Research|June 11, 2009
Antitumor activity with CYP17 blockade indicates that castration-resistant prostate cancer frequently remains hormone drivenGerhardt Attard, Alison H M Reid, David Olmos, et al.
Pageof 50

Showing results (81-90 of 492) with videos related to

Sort By:
Pageof 50
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 4, 2016
Biopsy-Derived Biomarkers in Phase I Trials: Building Confidence in Drug DevelopmentTimothy A Yap, Udai Banerji, Johann S de Bono, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2010
Studies of TMPRSS2-ERG gene fusions in diagnostic trans-rectal prostate biopsiesGerhardt Attard, Johann S de Bono, Jeremy Clark, et al.
Genome Biology|September 16, 2014
The promise of circulating tumor cell analysis in cancer managementJoaquin Mateo, Marco Gerlinger, Daniel Nava Rodrigues, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|January 24, 2014
Opportunities and pitfalls of targeted therapeutic combinations in solid tumorsJoaquin Mateo, Michael Ong, Timothy A Yap, et al.
European Urology|September 5, 2017
Reply to Finn E. von Eyben, Irene Virgolini and Giandomenico Roviello's Letter to the Editor re: Silke Gillessen, Gerhardt Attard, Tomasz M. Beer, et al. Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017. Eur Urol 2018;73:178-211Silke Gillessen, Johann S de Bono, Oliver Sartor, et al.
Journal of Musculoskeletal & Neuronal Interactions|March 31, 2007
Influence of birth weight and early diet on peripheral bone in premenopausal Cambridge women: a pQCT studyM A Laskey, S de Bono, E C Smith, et al.
Nature Clinical Practice. Urology|November 6, 2008
CYP17 inhibition as a hormonal strategy for prostate cancerAlison Hm Reid, Gerhardt Attard, Elaine Barrie, et al.
BMJ (Clinical Research Ed.)|August 13, 2008
New prostate cancer drug: Prostate cancer's day in the sunGerhardt Attard, Alison H Reid, David Dearnaley, et al.
Current Oncology Reports|February 8, 2012
FGF receptor inhibitors: role in cancer therapyGennaro Daniele, Jesus Corral, L Rhoda Molife, et al.
Cancer Research|June 11, 2009
Antitumor activity with CYP17 blockade indicates that castration-resistant prostate cancer frequently remains hormone drivenGerhardt Attard, Alison H M Reid, David Olmos, et al.
Pageof 50